What is Biosimilar?

Biosimilar Biological Product

Quick Answer

A biosimilar is a biological product that is highly similar to an already approved reference biological product. It has no clinically meaningful differences in safety or effectiveness compared to the reference product.

Overview

Biosimilars are created to be similar to existing biologic drugs, which are complex products made from living organisms. Unlike generic drugs, which are exact copies of chemical drugs, biosimilars are not identical due to the complexity of biological substances. They undergo rigorous testing to ensure they work the same way as the original product and provide the same benefits to patients. The production of biosimilars involves a detailed process that includes matching the structure and function of the original biologic. For instance, if a patient is using a biologic drug for rheumatoid arthritis, a biosimilar can be introduced as a treatment option. This is important because it can help lower costs and increase access to necessary therapies for patients who need them. Biosimilars matter in pharmacology because they can enhance competition in the market, potentially leading to lower prices for patients and healthcare systems. They also offer an alternative treatment option for patients who may not respond well to the original biologic. By providing effective treatment options at a reduced cost, biosimilars can significantly impact healthcare accessibility.

Frequently Asked Questions

How are biosimilars different from generics?

Biosimilars are not identical copies like generics because they are derived from living organisms. They are similar but may have slight differences due to the complex nature of biological products.

Are biosimilars safe and effective?

Yes, biosimilars must undergo extensive testing to demonstrate that they are safe and effective for patients. Regulatory agencies require evidence that they have no significant differences from the reference product in terms of quality, safety, and efficacy.

What are some examples of biosimilars?

Examples of biosimilars include products like Zarxio, which is a biosimilar to Neupogen, used to stimulate white blood cell production. Another example is Amgen's Mvasi, a biosimilar to Avastin, which is used in cancer treatment.